Time trends and health inequalities of cirrhosis caused by metabolic Dysfunction-associated steatotic liver disease from 1990 to 2021: A global burden of disease study
MASLD-related cirrhosis has become a significant global public health challenge. In recent years, the global burden of the disease has been increasing due to changes in lifestyle and the rising burden of chronic diseases, particularly in low- and middle-income countries. Health disparities remain prominent, highlighting the need for targeted interventions to mitigate the impact of this disease across diverse populations.
Authors
- Zhenxiang An (ORCID: https://orcid.org/0009-0002-5112-9608)
- Weibo Wen (ORCID: https://orcid.org/0000-0002-9303-7341)
- Dong Liu (ORCID: https://orcid.org/0000-0002-9977-959X)
- Yifeng Li (ORCID: https://orcid.org/0009-0002-6994-9276)
- Qiang Su (ORCID: https://orcid.org/0000-0001-6398-632X)
- Min Yan (ORCID: https://orcid.org/0000-0002-9178-5565)
- Min Wu (ORCID: https://orcid.org/0000-0002-3865-3731)
- Xiaofang Yang (ORCID: https://orcid.org/0009-0002-5634-0293)
Institutions
- Guiyang College of Traditional Chinese Medicine (CN)
- Guizhou University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
Publication Details
- Journal
- Journal of Endocrinological Investigation
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1007/s40618-025-02631-3
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35